Analyst Consensus ?
ConsensusHold15 ratings
Bullish746.7%
Neutral746.7%
Bearish16.6%
Otis Worldwide Corporation · OTIS · FY2025 Q4 · Calendar Q1 2026
Otis leans on service and modernization as new equipment stays pressured
Otis's earnings support a service- and modernization-led growth thesis, but the evidence is mixed: operational momentum is strong while new-equipment weakness, China exposure, and a modest EPS miss constrain confidence.
Reported Before market openNYSEIndustrials
$25.25B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.03
Consensus $1.04
EPS surprise
-1.0%
Reported versus consensus
Reported revenue
$3.80B
Consensus $3.89B
Revenue surprise
-2.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-2.2%
Event window
SPY move
-0.0%
Same window
Abnormal move
-2.1%
Stock minus SPY
Volume
2.5×
Versus trailing sessions
Subsequent drift
+3.2%
Up to 20 sessions
OTISSPY benchmark
Ask FN2 about OTIS FY2025 Q4
Transcript, numbers and history already loaded
Why did OTIS fall 2.2% after missing EPS estimates in FY2025 Q4?What changed in OTIS's guidance and outlook in FY2025 Q4?Give me the bull and bear case for OTIS after FY2025 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, Otis reported stronger modernization momentum, including 43% Q4 order growth and a record backlog, while maintaining its outlook. The company also emphasized AI and IoT tools as additions to its service-efficiency strategy.
Guidance delta
Maintained; 2026 outlook calls for low-to-mid-single-digit organic sales growth, mid-to-high-single-digit service growth, and flat to slightly down new-equipment sales.
Key takeaways
- Service remained the primary growth engine, with 5% organic sales growth and 100-basis-point margin expansion in Q4.
- Modernization orders surged 43% in Q4 and backlog reached a record level, supporting management's multiyear growth view.
- Adjusted free cash flow reached a record $817 million in Q4; management also highlighted AI, IoT, and Gen3 investments.
Management priorities
- Expand the Gen3 product family and Skyrise and Link modernization packages.
- Scale AI inspection and AI-agent tools alongside the Otis One IoT platform.
- Continue bolt-on acquisitions and increase field-professional capacity to support service growth.
Follow OTIS with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$65.63Current
$75Low
$92.94Average
$119High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 23, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 23, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 23, 2026 |
| Barclays | Underweight | Underweight | Maintain | Apr 23, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Apr 8, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Apr 1, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 16, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 8, 2025 |
| Argus Research | Buy | Buy | Maintain | May 13, 2024 |
| UBS | Neutral | Neutral | Maintain | Feb 16, 2024 |
| Vertical Research | Hold | Buy | Downgrade | Jan 2, 2024 |
| HSBC | Hold | Hold | Maintain | Apr 19, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 2, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Oct 27, 2022 |
| Berenberg | Buy | Buy | Maintain | Jun 22, 2022 |
Named analyst price targets
Upside is calculated against the persisted current price $65.63. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Analyst unavailable | $77 | $66.68 | +17.3% | Sep 24, 2026 |
| Morgan Stanley | Analyst unavailable | $75 | $72.58 | +14.3% | Aug 10, 2026 |
| RBC Capital | Analyst unavailable | $90 | $73.19 | +37.1% | Jul 28, 2026 |
| Evercore ISI | Alexander Virgo | $95 | $69.92 | +44.8% | Jul 23, 2026 |
| Bernstein | Analyst unavailable | $90 | $70.41 | +37.1% | Jul 23, 2026 |
| Bernstein | Analyst unavailable | $97 | $71.27 | +47.8% | Jun 9, 2026 |
| Morgan Stanley | Analyst unavailable | $88 | $79.52 | +34.1% | Apr 24, 2026 |
| UBS | Analyst unavailable | $105 | $80.87 | +60.0% | Apr 23, 2026 |
| Barclays | Julian Mitchell | $77 | $77.88 | +17.3% | Apr 23, 2026 |
| New Street | Analyst unavailable | $98 | $84.58 | +49.3% | Jan 30, 2026 |
| Wells Fargo | Joseph O'Dea | $92 | $88.14 | +40.2% | Dec 15, 2025 |
| Barclays | Analyst unavailable | $92 | $93.38 | +40.2% | Oct 30, 2025 |
| Wolfe Research | Analyst unavailable | $109 | $90.4 | +66.1% | Oct 8, 2025 |
| Barclays | Julian Mitchell | $91 | $92.12 | +38.7% | Jan 8, 2025 |
| Wells Fargo | Joseph O'Dea | $100 | $92.12 | +52.4% | Jan 7, 2025 |
| Morgan Stanley | Chris Snyder | $97 | $92.43 | +47.8% | Sep 6, 2024 |
| Wells Fargo | Joseph O'Dea | $95 | $91.43 | +44.8% | Jul 25, 2024 |
| Argus Research | John Eade | $108 | $96.21 | +64.6% | May 13, 2024 |
| Melius Research | Rob Wertheimer | $119 | $98.57 | +81.3% | Apr 2, 2024 |
| Barclays | Julian Mitchell | $90 | $98.57 | +37.1% | Apr 2, 2024 |
| Argus Research | John Eade | $102 | $92.41 | +55.4% | Feb 22, 2024 |
| Cowen & Co. | Analyst unavailable | $95 | $84.86 | +44.8% | Feb 2, 2023 |
| Barclays | Analyst unavailable | $81 | $84.56 | +23.4% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $89 | $84.56 | +35.6% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $82 | $84.56 | +24.9% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $71 | $80.25 | +8.2% | Jan 5, 2023 |
| BNP Paribas | Miguel Borrega | $80 | $71.9 | +21.9% | Jul 4, 2022 |
| RBC Capital | Analyst unavailable | $98 | $73.32 | +49.3% | May 4, 2022 |
| Cowen & Co. | Analyst unavailable | $85 | $72.3 | +29.5% | Apr 26, 2022 |
| Barclays | Analyst unavailable | $80 | $73.75 | +21.9% | Apr 26, 2022 |
| Credit Suisse | Analyst unavailable | $81 | $74.6 | +23.4% | Apr 26, 2022 |
Track every rating change on OTIS the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationOtis Worldwide Corporation is a global leader specializing in the manufacturing, installation, and servicing of elevators and escalators, with significant operations in the United States, China, and numerous other international markets. The company's business is organized into two primary divisions: New Equipment and Service. Its New Equipment segment is responsible for the design, fabrication, sale, and fitting of a diverse array of passenger and freight elevators, escalators, and moving walkways, catering to residential and commercial properties, as well as large-scale infrastructure endeavors. Conversely, the Service segment offers extensive maintenance, repair, and modernization services aimed at upgrading existing elevator and escalator systems. Otis maintains a substantial global service footprint, employing approximately 34,000 service technicians across roughly 1,400 branches and offices. The company, established in 1853, is headquartered in Farmington, Connecticut.
Historical context
All OTIS earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- COSTFY2026 Q4 · September 24, 2026+3.2% EPS+2.9% move
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
Get the OTIS recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-29T23:40:58.329886+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T23:40:58.326510+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.